Search research articles
Contact Us
Filters
Showing results (91-100 of 490) with videos related to
Page
of 49
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
September 6, 2017
Update zum klinischen Einsatz von Inhibitoren mutierter Phosphokinasen beim Melanom
Ioana Cosgarea, Cathrin Ritter, Jürgen C Becker, et al.
International Journal of Cancer
|
July 19, 2002
Soluble HLA-DR is a potent predictive indicator of disease progression in serum from early-stage melanoma patients
Vera Rebmann, Selma Ugurel, Wolfgang Tilgen, et al.
European Journal of Dermatology : EJD
|
August 29, 2006
Jo-1 positive paraneoplastic systemic sclerosis in a patient with metastatic melanoma
Adina Thoelke, Hans-Peter Schmid, Robert Figl, et al.
Cancer Treatment and Research
|
October 24, 2007
New promises in the adjuvant, and palliative treatment of melanoma
Axel Hauschild, Dirk Schadendorf, Claus Garbe, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
September 6, 2017
Update on the clinical use of kinase inhibitors in melanoma
Ioana Cosgarea, Cathrin Ritter, Jürgen C Becker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 21, 2024
The Interplay between Metabolic Adaptations and Diet in Cancer Immunotherapy
Lena Espelage, Natalie Wagner, Jan-Malte Placke, et al.
Expert Opinion on Therapeutic Targets
|
October 28, 2018
Targeting SOX2 in anticancer therapy
Laura Hüser, Daniel Novak, Viktor Umansky, et al.
Stem Cells (Dayton, Ohio)
|
July 19, 2008
Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression
Sarah Eminli, Jochen Utikal, Katrin Arnold, et al.
Science (New York, N.Y.)
|
September 27, 2008
Induced pluripotent stem cells generated without viral integration
Matthias Stadtfeld, Masaki Nagaya, Jochen Utikal, et al.
Cancers
|
January 8, 2020
STAT3 Relays a Differential Response to Melanoma-Associated <i>NRAS</i> Mutations
James Kim, Daniel Novak, Christos Sachpekidis, et al.
Page
of 49
Search research articles
Search
Showing results (91-100 of 490) with videos related to
Sort By:
Page
of 49
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
September 6, 2017
Update zum klinischen Einsatz von Inhibitoren mutierter Phosphokinasen beim Melanom
Ioana Cosgarea, Cathrin Ritter, Jürgen C Becker, et al.
International Journal of Cancer
|
July 19, 2002
Soluble HLA-DR is a potent predictive indicator of disease progression in serum from early-stage melanoma patients
Vera Rebmann, Selma Ugurel, Wolfgang Tilgen, et al.
European Journal of Dermatology : EJD
|
August 29, 2006
Jo-1 positive paraneoplastic systemic sclerosis in a patient with metastatic melanoma
Adina Thoelke, Hans-Peter Schmid, Robert Figl, et al.
Cancer Treatment and Research
|
October 24, 2007
New promises in the adjuvant, and palliative treatment of melanoma
Axel Hauschild, Dirk Schadendorf, Claus Garbe, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
September 6, 2017
Update on the clinical use of kinase inhibitors in melanoma
Ioana Cosgarea, Cathrin Ritter, Jürgen C Becker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 21, 2024
The Interplay between Metabolic Adaptations and Diet in Cancer Immunotherapy
Lena Espelage, Natalie Wagner, Jan-Malte Placke, et al.
Expert Opinion on Therapeutic Targets
|
October 28, 2018
Targeting SOX2 in anticancer therapy
Laura Hüser, Daniel Novak, Viktor Umansky, et al.
Stem Cells (Dayton, Ohio)
|
July 19, 2008
Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression
Sarah Eminli, Jochen Utikal, Katrin Arnold, et al.
Science (New York, N.Y.)
|
September 27, 2008
Induced pluripotent stem cells generated without viral integration
Matthias Stadtfeld, Masaki Nagaya, Jochen Utikal, et al.
Cancers
|
January 8, 2020
STAT3 Relays a Differential Response to Melanoma-Associated <i>NRAS</i> Mutations
James Kim, Daniel Novak, Christos Sachpekidis, et al.
Page
of 49